Lenalidomide Celgene Europe (lenalidomide)
- Region
- 🇪🇺 EU
- Active substance
- lenalidomide
- Company
- Celgene Europe Limited
- Status
- Application withdrawn
- Therapeutic area
- Myelodysplastic Syndromes
- Application
- EMEA/H/C/000688
- Official record
- www.ema.europa.eu
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Lenalidomide Mylan Authorised · Mylan Pharmaceuticals Limited
- 🇪🇺 Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Authorised · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Lenalidomide Accord Authorised · Accord Healthcare S.L.U.
- 🇪🇺 Revlimid Authorised · Bristol-Myers Squibb Pharma EEIG
- 🇪🇺 Lenalidomide Krka d.d. Withdrawn · KRKA tovarna zdravil d.d. Novo mesto
- 🇪🇺 Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) Authorised · KRKA tovarna zdravil d.d. Novo mesto
Follow Lenalidomide Celgene Europe
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.